BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer

被引:19
|
作者
Erturk, Elif [1 ]
Cecener, Gulsah [2 ]
Tezcan, Gulcin [2 ,3 ]
Egeli, Unal [2 ]
Tunca, Berrin [2 ]
Gokgoz, Sehsuvar [4 ]
Tolunay, Sahsine [5 ]
Tasdelen, Ismet [4 ]
机构
[1] Uludag Univ, Vocat Sch Hlth Serv, Bursa, Turkey
[2] Uludag Univ, Dept Med Biol, Fac Med, Bursa, Turkey
[3] Uludag Univ, Inst Hlth Sci, Dept Med Biol, Bursa, Turkey
[4] Uludag Univ, Dept Gen Surg, Fac Med, Bursa, Turkey
[5] Uludag Univ, Dept Pathol, Fac Med, Bursa, Turkey
关键词
Triple negative breast cancer; MicroRNA; BRCA1/2 gene mutations; miR-200c; EPITHELIAL-MESENCHYMAL TRANSITION; DOWN-REGULATION; OVARIAN-CANCER; FEEDBACK LOOP; FAMILY; ZEB1; MICRORNA-200C; PROGRESSION; METASTASIS; RESISTANCE;
D O I
10.1016/j.gene.2014.11.047
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Triple negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer (BC). Over the recent years, miRNA expression studies have been providing certain detailed overview that aberrant expression of miRNAs is associated with TNBC. Although TNBC tumors are strongly connected with loss of function of BRCA genes, there is no knowledge about the effect of BRCA mutation status on miRNA expressions in TNBC cases. The aims of this study were to evaluate the expression profile of miRNAs that plays role in TNBC progression and the role of BRCA mutations in their regulation. The expression level of BC associated 13 miRNAs was analyzed in 7 BRCA mutations positive, 6 BRCA mutations negative TNBC cases and 20 non-tumoral tissues using RT-PCR. According to RT2 Profiler PCR Array Data Analysis, let-7a expression was 4.67 fold reduced in TNBCs as compared to normal tissues (P = 0.031). In addition, miR-200c expression was 5.75 fold reduced in BRCA mutation positive TNBC tumors (P = 0.005). Analysis revealed a negative correlation between miR-200c and VEGFA expressions (r = -468). Thus, miR-200c may be involved in invasion and metastasis in TNBC cases with BRCA mutation. In this study we provide the knowledge on the first report of association between microRNA-200c and BRCA mutations in TNBC. Further studies and evaluations are required, but this miRNA may provide novel therapeutic molecular targets for TNBC treatment and new directions for the development of anticancer drugs. (C) 2014 Published by Elsevier B.V.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 50 条
  • [1] Inhibitory effect of miR-200c on EMT in triple negative breast cancer and its mechanism
    Dehua, Z.
    Xiaotian, M.
    Shouhua, R.
    Yuchao, Z.
    Jinfang, X.
    Yuan, T.
    Ying, S.
    Liting, J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1522 - 1522
  • [2] Differential expression of miR-200c in breast cancer stem cells
    Wu, Dijun
    Ji, Ning
    Zhang, Lei
    Zhang, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (09): : 10085 - 10091
  • [3] miR-205 and miR-200c: Predictive Micro RNAs for Lymph Node Metastasis in Triple Negative Breast Cancer
    Berber, Ufuk
    Yilmaz, Ismail
    Narli, Gizem
    Haholu, Aptullah
    Kucukodaci, Zafer
    Demirel, Dilaver
    JOURNAL OF BREAST CANCER, 2014, 17 (02) : 143 - 148
  • [4] Tamoxifen reverses epithelial mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells
    Wang, Qian
    Cheng, Yu
    Wang, Yan
    Fan, Yibo
    Li, Ce
    Zhang, Ye
    Wang, Yiding
    Dong, Qian
    Ma, Yanju
    Teng, Yue-e
    Qu, Xiujuan
    Liu, Yunpeng
    BMC CANCER, 2017, 17
  • [5] Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression
    Rogers, Thomas J.
    Christenson, Jessica L.
    Greene, Lisa, I
    O'Neill, Kathleen, I
    Williams, Michelle M.
    Gordon, Michael A.
    Nemkov, Travis
    D'Alessandro, Angelo
    Degala, Greg D.
    Shin, Jimin
    Tan, Aik-Choon
    Cittelly, Diana M.
    Lambert, James R.
    Richer, Jennifer K.
    MOLECULAR CANCER RESEARCH, 2019, 17 (01) : 30 - 41
  • [6] Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells
    Qian Wang
    Yu Cheng
    Yan Wang
    Yibo Fan
    Ce Li
    Ye Zhang
    Yiding Wang
    Qian Dong
    Yanju Ma
    Yue-e Teng
    Xiujuan Qu
    Yunpeng Liu
    BMC Cancer, 17
  • [7] Prognostic significance of triple miRNAs, miR-9, miR-221, and miR-200c in breast cancer
    Cheng, Chun-Wen
    Yu, Jyh-Cherng
    Hsieh, Yi-Hsien
    Chen, Po-Ming
    Wang, Hsiao-Wei
    Wang, Hui-Chun
    Shen, Chen-Yang
    CANCER RESEARCH, 2015, 75
  • [8] Pathogenetic mutations in BRCA related triple negative breast cancer
    Bini, F.
    Ballatore, Z.
    Bianchi, F.
    Maccaroni, E.
    Belvederesi, L.
    Brugiati, C.
    Pagliaretta, S.
    Murrone, A.
    Savini, A.
    Pistelli, M.
    Bracci, R.
    Berardi, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] (-)-Sativan Inhibits Tumor Development and Regulates miR-200c/PD-L1 in Triple Negative Breast Cancer Cells
    Peng, Fu
    Xiong, Liang
    Peng, Cheng
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [10] miR-200c inhibits breast cancer proliferation by targeting KRAS
    Song, Cailu
    Liu, Long-Zhong
    Pei, Xiao-Qing
    Liu, Xiaoping
    Yang, Lu
    Ye, Feng
    Xie, Xinhua
    Chen, Jianping
    Tang, Hailin
    Xie, Xiaoming
    ONCOTARGET, 2015, 6 (33) : 34968 - 34978